Thyroid hormones (TH or T3) and their DNA binding nuclear receptors (TRs), direct 26 transcriptional regulation in different ways depending on the host cell environment and specific promoter 27 characteristics of TH sensitive genes. This study sought to elucidate the impact on repression of nucleotide 28 sequence/orientation of TR binding sites, TR elements, (TREs) within TH sensitive promoters. 29
Introduction 51
Thyroid hormones (TH or T3) and their nuclear receptor family members Thyroid Hormone 52
Receptors (TRs) have the ability to increase and decrease the rate of transcription of target genes (Lazar, 53 1993). These target genes generally contain a thyroid response element, TRE, arrangements of single or 54 multiple DNA hexamers recognized and bound by the DNA binding domain (DBD) of TR (Yen, 2001) . A 55 host of criteria such as T3 binding to TRs, TR isoforms binding to target gene promoter regions as 56 monomers, homo or hetero dimers, and the number of, arrangement and sequence of TREs determine the 57 type of regulation (Yen, 2001 ). These criteria and their outcomes are extensively studied but still poorly 58 understood for most thyroid hormone sensitive genes, which T3 decreased the target gene expression. 59
It is generally understood that certain TRE arrangements known as direct repeat fours, DR4, consensus 60 AGGT(C/G)A nnnn AGGT(C/G)A, are bound by a TR and retinoid X receptor (RXR) heterodimer which 61 recruit corepressor complexes to the target genes promoter region which modify the bound histones to 62 repress transcription. When T3 as a ligand binds to the receptor a conformational change causes the 63 corepressors to leave and be replaced by coactivators that modify the histones to attract the transcription 64 machinery. Alternatively, several TREs with arrangements known as palindromes, often found on genes 65 related to the feedback inhibition of T3 synthesis, regulate transcription in an opposite manner (Chatterjee 66 et al., 1989). For these negative TREs (nTRE) the un-ligand TR somehow activated gene expression and 67 then conferred repression upon binding T3 however this type of regulation is not well described possibly 68 due to the conflicting circumstances for different genes that contain similar nTREs. There is argument over 69 whether TR/DNA binding is maintained and what cofactors are involved because there has been evidence 70 to support many different hypotheses depending on the system/cell line and gene being studied. We have set out to better understand the precise TK nTRE nucleotide and TR/RXR residue 82 interactions that define this protein-DNA binding, using web-based molecular biology applications to steer 83 our benchtop TK nTRE site directed mutagenesis experiments. Performing a point mutation on a 84 computationally identified nucleotide within the TRE, we generated a mutant that exhibited reversal of T3 85 sensitivity measured by dual luciferase assays. The luciferase reporter system has been used by several labs 86 to evaluate nTREs in a variety of promoters including TSHα, TSHβ and HSV-1 TK (Lalli and Sassone-87 
Experimental Procedures 93

Computational analyses of protein-DNA binding 94
The protein data bank (pdb) file 2NLL which depicts the crystallography structure of the RXR and 95 TR heterodimer bound to a traditional TRE sequence 5'-CAG GTC ATT TCA GGT CAG-3' was 96 manipulated using the Swiss PDB Viewer, SPV, (http://spdbv.vital-it.ch/) (Johansson et al., 2012) to obtain 97 2 separate pdb files for each protein monomer bound to a 5'-AGGTCA-3' hexamer TRE half-site. The 98 interaction of TREs and nuclear receptors was computationally analyzed by the web based application 99 PiDNA (http://dna.bime.ntu.edu.tw/pidn) (Lin and Chen, 2013). Each monomer-hexamer pdb was used as 100 a template in the PiDNA web application to computationally predict the binding affinities of the monomers 101 to the wild type hexamers and randomly generated single base pair mutant hexamers. 
Construction of TRE mutant plasmid 114
The wild-type TK reporter plasmid pGL4.74-hRluc/TK was purchased from Promega (Cat # 115 E6921). The single nucleotide mutation was introduced into the promoter region using Phusion Site-116 Directed Mutagenesis Kit from Thermo Fisher Scientific (Cat#: F-541) as described by the manufacturer. 117
In short, template plasmid pGL4.74 was used in a PCR reaction using mutagenesis primers with 5' 118 phosphorylation modifications. The PCR reaction resulted in amplified linear point mutated plasmid in its 119 entirety followed by a ligation to cyclize the linear PCR product to form circular plasmid containing single 120 point mutation. The sequence and size of the generated plasmid were confirmed by gel electrophoresis and 121 sequencing. The computational results discussed in a later section and depicted in Fig. 1 led to the 122 development of the forward, 5'-tcgcatattaaggtgccgcgtgtggc-3', and reverse, 5'-agtggacctgggaccgcgcc-3', 123 primer used for mutagenesis and strategy depicted in Fig. 2 . 
Reporter assays 144
Luciferase activity was measured by a luminometer using the Dual-Luciferase reporter assay 145 system (Cat#: PR-E1910, Promega). The cell lysate was collected for the luciferase assay after 48 h of 146 transfection essentially described by the manufacturer. Luminescence was measured over a 10-s interval 147 with a 2-s delay on the Synergy HTX multi-mode plate reader (Cat#: S1L, Biotek). The renilla luciferase 148 activities were normalized against the internal firefly luciferase control driven by HSV-1 VP16 promoter 149 to correct for transfection efficiency. The results were presented as the percent induction of the reporter 150 plasmid in the presence or absence of T3 (100 nM Scientific). The manufactures protocol was followed using 3'-biotin modified oligos corresponding to the 160 wild type and TRE1 mutant sequences. The oligos were annealed and incubated with protein extracts from 161 Protein Extracts were prepared from undifferentiated or differentiated LNCaP cells grown in T75s 171 treated overnight with or without T3. Protein was isolated using RIPA buffer (Thermo Scientific cat# 89900) 172 based on the protocol of the manufacturer. Briefly, the cells were washed twice with cold DPBS and 173 exposed to cold RIPA buffer with Halt protease inhibitor cocktail (Thermo Sci cat# 78410) for 5 min onice with gentle rocking. The lysate was scraped and collected followed by centrifuging at 14,000 × g for 15 175
minutes to pellet the cell debris. The supernatant was used for EMSA assays. 176
177
Chromatin Immuno-precipitation (ChIP) 178
The ChIP was performed using ChromaFlash High-Sensitivity ChIP Kit from Epigentek, 179
Farmingdale, NY (Cat#: P-2027-48). The protocol was described per the manufacturer. In short, test PiDNA also suggested an alternative binding to 5'-GCGTCA-3' (TRE-1b) located at the reverse strand 214 (Fig. 1A) . This half-site exhibited the same binding strength in comparison to TRE-1a (data not shown). 215
Computational observations revealed that a TRE-1a 6A/C mutation on the positive strand to 216 become 5'-AAGTGC-3' would create a new TRE-1b' with half-site sequence of 5'-GCGGCA-3' on the 217 reverse strand identified by PiDNA as preferentially bound by RXR in comparison to TRE-1a' ( on the mutant promoter. The mutant TRE1b' would gain one more hydrogen bond from Arg160 from the 222 RXRα (Fig. 1B) to strengthen the interaction which is absent from the wild type. in the T3 -mediated negative regulation, a point mutation was introduced followed by reporter assays to 233 study the regulatory effects. For easy discussion, the TRE adjacent to TATA box was named TRE1 and the 234 other one was called TRE2 (Fig. 2) . The mutation was introduced to the end of TRE1 from 5'-AGGTGA-235 3' to 5'-AGGTGC-3' (Fig. 2, mtTRE1 ). The original TK TRE was named wtPal6. The resulting plasmid 236 mtTRE1 was confirmed by sequencing (data not shown). 237
TK promoter and its mutant were not regulated by T3 in undifferentiated LNCaP cells 238
These reporter plasmids were first tested by dual luciferase (DLuc) assay after transfection of 239 undifferentiated LNCaP cells treated with and without T3. DLuc assays showed that the T3 treatment did 240 not affect the promoter activity of any plasmid (Fig. 3A) , indicating that there is no T3 -mediated regulation 241 in undifferentiated cellular environment. 242
243
TK single nucleotide mutant reporter plasmids exhibited distinct T3 -mediated regulation in 244 differentiated LNCaP cells 245
The plasmids were later transfected into differentiated LNCaP cells with or without T3 treatment. 246 Fig. 3B shows T3 treatment caused a 10-fold reduction in wtPal6 promoter activity, consistent with our 247 previous finding that T3 mediated a negative regulation in differentiated cellular background. In contrast 248 mtTRE1 activity showed the opposite regulatory profile with a 4-fold increase upon T3 treatment (Fig. 3B,mtTRE1 panel) . In differentiated LNCaP, under T3 the wt promoter activity was at least 70-fold weaker 250 than mtTRE1 (Fig. 3B) Shifted bands were detected where the addition of T3 slightly reduced the band intensity (compare Fig. 4A , 259 lane 2 and 3). The decreased interaction by T3 was more significant if longer electrophoresis was allowed 260 (Fig. 4C, lane 2 and 3 ). These observations demonstrated that proteins from the extract interacted with the 261 TRE oligo and T3 reduced the binding. To address if TR contributed to the binding to the TRE, antibodies 262 against TR or RXR were introduced in the EMSA. The results showed that the retardation bands were 263 completely abolished upon the addition of anti-TR Ab and only slightly affected upon the addition of anti-264 RXR Ab (Fig. 4A , lane 4-5 and 6-7, respectively), supporting that TR played a critical role in this 265 interaction, perhaps by direct binding to the TK-TREs with RXR functioning as a partner. 266
267
TK-TREs were not bound by TR from undifferentiated cells 268
Protein extract from undifferentiated LNCaP cells of equivalent total protein concentrations used 269 in differentiated extract experiments in Fig. 4A were used to compare the TRE/TR interaction. Surprisingly 270 the strong interaction between wtTRE and TR from differentiated cells (Fig. 4B, lane 8) was not observed 271 (Fig. 4B, lane 1-7 ) even though TR is detectable at this dilution (data not shown). The mutant TRE oligo 272 yielded similar results of no interaction (Fig. 4B, lane 9-15 To mimic the physiological condition, we pretreated differentiated LNCaP cells with T3 for 48 279 hours and wash the cells with PBS followed by protein extraction (prior T3 pretreatment). It was noted that 280 T3 -pretreated protein extracts caused the band intensity to increase upon T3 addition (compare Fig. 4C , 281 lane 4 and 5). Upon addition of anti-TR Ab, the lane lacking T3 binding treatment nearly disappeared (Fig.  282 4C, lane 6) whereas its T3 treated counterpart band was still clearly visible with reduced intensity (Fig. 4C , 283 lane 7), suggesting that ligand TR, if pretreated with hormone, exhibited a stronger binding capacity to 284
TREs. The addition of anti-RXR Ab had little effect on these bands (Fig. 4C, Lane 8 and 9) . (Fig. 4D, lane 4 and 5) . Unlike the wtTRE, the addition of anti-RXR Ab also 291 reduced the band signal, which suggested that RXR was also involved in DNA binding on the mtTRE (Fig.  292 4C, Lane 6 and 7). Together these observations suggested that the mutation disrupted the interaction of 293 nuclear hormone receptors to the wild-type TRE thus altering the negative regulation. 294
295
Repressive chromatin H3K9me3 enriched at wt promoter in the presence of T3 was released in 296 mtTRE1 promoter 297
ChIP was performed to investigate the impact of single nucleotide change of the TREs on the 298 chromatin recruitment to the promoter. In this experiment using an antibody against H3K9me3, a repressive 299 histone previously reported to be associated with TK promoter with T3 (Figliozzi et al., 2014) , we showed 300 that in the wt promoter the tri-methylated histone interaction was increased 4.3-fold upon T3 addition (Fig.  301 5A), in agreement with our hypothesis that T3 mediated repression in differentiated cells. In contrast the 302 opposite effect was shown for the mtTRE1, where H3K9me3 recruitment decreased by as many as 5.5-fold 303 in the presence of T3 (Fig. 5A ). This result indicated that one nucleotide mutation shifted the histone profile 304 under the same condition. 305
306
Transcription factor Sp1 occupancy was reversed by TRE sequence changes 307
Recruitment of transcription factor was studied by ChIP Assays using antibodies against Sp1. It 308 was revealed that Sp1 recruitment to the wt promoter increased 4-fold without T3, whereas decreased 309 approximately 3-fold in the mtTRE1 promoter ( to modulate the TR/TRE interaction. It cannot be ruled out that differentiated and undifferentiated 361 conditions generated distinct chromatin environments allowing these discrete interactions. 362
The occupancy of transcription factor Sp1 to the TK promoters with different TREs was assessed. 363
The ChIP results matched the Dluc assays and indicated that Sp1 occupancy promoted active transcription 364 in the absence of T3 (compare Fig. 3B and Fig. 5B ). It is worth noting that in the presence of T3, Sp1 365 recruitment to mtTRE1was enhanced by 16-fold in comparison to wtTRE (Fig. 5B) . It seemed that Sp1 366 binding was determined, at least in part, by TR binding (compare Fig. 5B to Fig. 4C and 3D ) and the ligand 367 appeared to play a critical role. Position weight matrix comparison of the wild type and mutant promoter 368 for Sp1 binding sites did not reveal additional sites upon mutation (data not shown). Two Sp1 binding sites 369 are not found overlapping the TK TRE but well upstream of the TATA box (-111 bp and -59 bp), therefore 370 the mutations did not affect the Sp1 binding site but still altered its binding profile (Coen et al., 1986) . It is 371 unclear how the mutation achieved this phenomenon. We therefore speculate that in both cases T3 372 modulated histone modification and the resulting chromatin environment at this promoter determined Sp1 373 occupancy. In conclusion, the unique negative TREs of HSV-1 TK were characterized in this report by side-385 directed mutagenesis. T3 was not sufficient to control TK promoter activity in undifferentiated condition 386 but conferred repression while cells were differentiated. A point mutation at TRE1 close to TATA box 387 changed the T3 -mediated negative regulation into positive fashion. In vitro EMSA suggested this wide 388 spaced TREs would favor TR monomer binding and strong TR interaction to the TREs particularly in the 389 presence of T3 during differentiation. Ligand TR under differentiation appeared to suppress TK 390 transcription by creating a repressive chromatin environment and by reducing the recruitment of the 391 important transcription factor Sp1 to the promoter. This understanding of this complex regulation may have 392 implication to control alpha herpes virus infection and reactivation. 393
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The authors declare no conflict of interest. The interactions of protein and DNA were investigated by PiDNA, a web based application, 572 to interpret the results from the biochemical assays. The high-scored putative TRE half-sites were 573
further assessed for hydrogen bond interactions using Python Molecule Viewer (PMV) software 574 and PDBSum. PMV was used to visualize and measure distances between the DNA binding 575 protein residues and the bases of the DNA TRE half-sites. PDBSum calculates and diagrams 576 putative hydrogen bonds between the DNA and the Protein in the pdb files. 577
A. Random screening of PiDNA identified 5'-AGGTGA-3' (TRE-1a) on the positive strand and 578 5'-AGGCCA-3' (TRE-2) located at the reverse strand of the HSV-1 TK promoter as the best 579 half-sites for protein binding. The orientation of these half-sites for TRE-1 and TRE-2 was 580 suggested as palindromic TREs with a six nucleotide in between (Pal 6). The point mutation 581 changed the TRE-1a to 5'-AGGTGC-3' and TRE-1b to 5'-GCGGCA-3' on the reverse 582 strand. This shift would allow TRE-1b' and TRE-2 to form a direct repeat separated by three 583 nucleotides (DR 3), presumably to generate positive regulation. 584 B. PDBSum hydrogen bonding analysis of TRβ and RXRα hydrogen bonding to 5'-AGGTGA-585 3' (wt TRE-1a), 5'-AGGTGC-3' (mt TRE-1a'), and 5'-GCGGCA-3' (mt TRE-1b') suggested 586 strongest binding to TRE-1b' after the mutation due to one more hydrogen bond established 587 from Arg160 of the RXRα. 
